Dr. Shirish Kulkarni is currently working as a CSO for Pharmwell Global at San Francisco Bay area with a primary focus on developing innovative and novel pharmaceutical dosage forms. He came to Canada in 1991 for his master's degree and to USA in 1993 for his Ph.D. studies. After completion of Ph.D., he worked in a few pharma companies in USA prior to returning to India in 2006. In India, he worked for Lupin in Pune where he established Innovation Cell and contributed significantly to Lupin's phenomenal growth during that period. In 2013, he joined Sun Pharma and spearheaded R&D and contributed to development of several Pharmaceutical products. In 2019, he again moved to USA to establish Pharmwell Global. He has been honorary member of Sigma Xi and Phi Kappa Phi scientific organizations. He has over 55 patents, 30 scientific publications and presentations in various international journals and conferences. Currently, he lives in Bay area with a wife and two children, a daughter and a son. Both children are working in Bay area as well.